NATH BIOGENES (INDIA)
Back to Income Statement
|
NATH BIOGENES (INDIA) Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹39 Cr | ₹40 Cr | ₹35 Cr | ₹-67 Cr | ₹12 Cr |
What is the latest Consolidated Net Profit of NATH BIOGENES (INDIA) ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹39 Cr |
| Mar2024 | ₹40 Cr |
| Mar2023 | ₹35 Cr |
| Mar2022 | ₹-67 Cr |
| Mar2013 | ₹12 Cr |
How is Consolidated Net Profit of NATH BIOGENES (INDIA) Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹39 Cr | -2.57 | |
| Mar2024 | ₹40 Cr | 13.11 | |
| Mar2023 | ₹35 Cr | Positive | |
| Mar2022 | ₹-67 Cr | Negative | |
| Mar2013 | ₹12 Cr | - | |
Compare Consolidated Net Profit of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹270.9 Cr | 1.5% | -4.6% | -6.5% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,634.6 Cr | -0.8% | -17.7% | -12.5% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,168.6 Cr | 5.6% | -9.3% | -24.5% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,709.7 Cr | -4.1% | -15.9% | -24.1% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹861.0 Cr | -1.6% | -10.7% | -38.2% | Stock Analytics | |
| INDO US BIOTECH | ₹198.8 Cr | -3.1% | -24.8% | -46.6% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | 1.5% |
-4.6% |
-6.5% |
| SENSEX | -5.5% |
-11.5% |
0.3% |
You may also like the below Video Courses